NCT04870580View on ClinicalTrials.gov

[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy

NAActive, not recruitingINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Glioma

Interventions

DIAGNOSTIC_TEST

Fluorodopa PET tracer

PET/CT scan using fluorodopa tracer

Trial Locations (1)

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Collaborators (1)

Cancer Research UK

All Listed Sponsors

collaborator

Cancer Research UK

OTHER

collaborator

University of Oxford

OTHER

lead

University College, London

OTHER

NCT04870580 - [18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy | Biotech Hunter | Biotech Hunter